Oncomedics is a biotechnology company that specializes in the research of personalized treatments against cancer. It collects human cancer tumor from patients to obtain cancer primary culture as models for cancer research, drug screening, biomarker validation, and individualized diagnostics. The company also develops Oncogramme, a technique that helps to evaluate experimental drug efficiency on a panel of tumoral cell from distinct patient.